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TNF-α & IL-6
Cytokines mostly produced by
macrophages. Higher expression in obesity
(systemic inflammatory state).
IL-6
Activates: SOCS3, MAPKs and PKC.
TNF-α: 
Activates: IKK  NF-κB, S6K, JNK1.
Inhibits: GLUT 4, ACS, JNK and perilipin.
Increases cytokine production and
expression and lipid accumulation.
Modulates gene expression.
Insulin resistance is the cell’s incapacity to respond to the normal actions of the hormone that leads to a
aaaaaaaaaaaaaaaaaaa decrease in cell survival, glucose uptake and the synthesis of protein, glycogen and fatty acids. Insulin exerts
its immediate effects via the activation of the IR/IRS/PI3K/PKB signaling pathway. Molecules related with the adipose tissue can
modulate this pathway, increasing or decreasing insulin sensitivity. Some of these molecules are adiponectin, leptin, resistin and
inflammatory factors such as tumor necrosis factor alpha (TNF-α) and interleukine 6 (IL-6).
Antidiabetic Drugs
Biguanides
Metformin is the most used biguanide.
Targets: AMPK and PPAR  fatty acid oxidation increase/ lipogenesis block.
Insulin sensitivity increase: ↑ peripheral glucose and glucose uptake
↓ hepatic glucose production.
Thiazolidinediones (TZDs)
Targets: AMPK and PPARɣ
Insulin sensitivity increase: ↑ glucose use for energy expenditure
inflammatory cytokines block
Adiponectin
It increases fatty acid oxidation and
improves insulin sensitivity.
Targets: AMPK and PPAR.
Activates: TSC and fatty acid transporters.
Reduces: mTORC, ACC, IKK, SREBP and
ChREBP.
Increases glucose uptake via GLUT 4
translocation. Reduces gluconeogenesis by
blocking PEPCK and G6P.
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INTRODUCTION
Leptin
It decreases hunger, thermogenesis and
fatty acid oxidation.
Leptin resistance State: hormone levels are
high but cells don’t respond to it. It appears
in obese patients.
Caused by: BBB transport deficiency AND
SOCS3 activation: inhibits JAK/STAT
leptin signaling pathway.
Increases lipogenesis (c-fos and SREBP
activation). ↑ insulin 
resistance
Resistin
It recruits proinflammatory factors and
immune cells. It’s mostly produced by
monocytes and macrophagues.
Decreases: AMPK, PPAR, PKB activity,
ROR activation and Foxo1 expression.
Activates: GSK3, ERK1/2 and SOCS3.
Increases gluconeogenesis and lipogenesis.
Human relevance not proved. ↑ insulin 
resistance
Adipose tissue’s related molecules modulate insulin resistance, promoting this pathology in overweight status.
DfsdfsdfsduuuuuuuuuuuInsulin resistance can also be seen in veterinary medicine, with a lower prevalence, mostly related with an
animal’s inadequate nutrition or life style that lead to obesity. Two antidiabteic drugs broadly used, Metformin and TZDs, have the same
targets: AMPK and PPAR, making clear that both molecules have a crucial role in insulin resistance. There is a need for further
research since many of the mechanisms involved in this pathology remain incompletely understood and the perspectives of finding new
drugs are favorable.
CONCLUSIONS
Fig. PPAR multiple roles (Ahmadian, M. et al., 2013).
ABBREVIATIONS: Insulin receptor (IR); insulin receptor substrates (IRS); phosphoinositide-dependent kinase-1 (PDK1); protein kinase B (PKB); AMP-activated protein kinase (AMPK); peroxisome
proliferator-activated receptors (PPAR); tuberous sclerosis complex (TSC); mammalian target of rapamycin complex 1&2 (mTORC1/2); acetyl Co-A carboxylase (ACC), IκB kinase (IKK); sterol
regulatory element-binding protein (SREBP); carbohydrate-responsive element-binding protein (ChREBP); phosphoenolpyruvate carboxykinase (PEPCK); glucose 6-phosphatase (G6P); blood-brain
barrier (BBB); supressor of cytokine signaling 3 (SOCS3); janus-kinase/signal transducers and activators of trascription (JAK/STAT); mitogen-activated protein kinase (MAPKs); protein kinase C
(PKC); nuclear factor-κB (NF-κB); c-Jun N-terminal kinases (JNK); glycogen synthse kinase 3 (GSK3); extracellular signal-regulated kinases 1&2 (ERK1/2); tyrosine-protein kinase transmembrane
receptor (ROR).
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